2269:HKG
WuXi Biologics (Cayman) Inc
HK$Â 48,20
arrow_downward
-0,90%(-0,44) 1D
16 okt, 16:08:14 GMT+8 · HKD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 2269 genereren…
Openen
HK$Â 49,98
Hoog
HK$Â 50,85
Laag
HK$Â 45,82
Beursw.
198,43Â mld.
Gem. vol.
30,42Â mln.
Volume
55,18Â mln.
Koers/winst-verhouding
34,48
52 wk hoog
HK$Â 58,00
52 wk laag
HK$Â 28,48
WPA
HK$Â 1,40
Uitstaande aandelen
1,23Â mld.
Aantal medewerkers
15K
Openen
HK$Â 49,98
Hoog
HK$Â 50,85
Laag
HK$Â 45,82
Beursw.
198,43Â mld.
Gem. vol.
30,42Â mln.
Volume
55,18Â mln.
Koers/winst-verhouding
34,48
52 wk hoog
HK$Â 58,00
52 wk laag
HK$Â 28,48
WPA
HK$Â 1,40
Uitstaande aandelen
1,23Â mld.
Aantal medewerkers
15K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Vietnam.vn
·
1 dag geleden
De S&P 500 kende de scherpste wekelijkse daling sinds juni 2026.
Blockchain Stories
·
19 uur geleden
S&P 500 stijgt 11,6% dit jaar, maar angst domineert de markt
MarketScreener Nederland
·
1 dag geleden
Nasdaq beëindigt reeks van vier wekelijkse winsten door uitverkoop in technologiesector
Invezz
·
1 dag geleden
Dow opent 240 punten hoger terwijl AI-aandelen dalen en inflatiezorgen drukken
Profiel
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Over WuXi Biologics (Cayman) Inc